APPLICATIONS PUBLISHED 10 APRIL 2002

Published: 1-Nov-2002

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492

  • Transgenically produced anti-thrombin III and mutants thereof
    Genzyme Transgenics 1194033*

  • Preservatives for perishable preparations, in particular for cosmetic and pharmaceutical preparations
    Schott Glas 1194113*

  • Topically-applied idebenone-containing agent wth protective and regenerative effect
    Neudecker, Birgit; Wieland, Eberhard; Diedrich, Falko 1194115*

  • Controlled release of therapeutics by in-situ entrapment by matrix cross-linking
    University of Medicine and Dentistry of New Jersey 1194119*

  • Clear oil-containing pharmaceutical compsns
    Lipocine 1194120*

  • Steroid solution aerosol products with enhanced chemical stability
    3M Innovative Properties 1194121*

  • Methods and preparation of lipid-encapsulated therapeutic agents
    Inex Pharmaceuticals 1194122*

  • Method for controlled production of ultrafine microparticles and nanoparticles
    Pharmasol 1194123*

  • Taste masked compsns
    Ranbaxy Laboratories 1194124*

  • Method for making granules with masked taste and instant release of the active particle
    Ethypharm 1194125*

  • Dry powder compsns
    Quadrant Healthcare 1194126*

  • Method for producing powdery particle-reduced formulations with the aid of compressed gases
    SKW Trostberg 1194127*

  • Ionically formulated biomolecule microcarriers
    Sedum Laboratories 1194128*

  • Self-emulsifying systems containing anticancer medicament
    Abbott Laboratories 1194129*

  • Improvements in and relating to delivery capsules
    Bioprogress Technology International 1194130*

  • Pharmaceutical dosage forms for controlled release producing at least a timed pulse
    Sanofi-Synthelabo 1194131*

  • Timed dual release dosage forms comprising a short-acting hypnotic or a salt thereof
    Sanofi-Synthelabo 1194132*

  • Multilayered film containing an active substance and made from cross-linked hydrophilic polymers
    Gruenenthal 1194134*

  • Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
    The UAB Research Foundation 1194135*

  • Non-solid compsn for local application
    Shrivastava, Ravi 1194136*

  • Naphthoquinone derivatives and their use in the treatment and control of tuberculosis
    University of Pretoria 1194137*

  • Nutritional supplements
    Drugtech Corp 1194138*

  • Pharmaceutical compsn containing fenofibrate and preparation method
    Laboratoires des Produits Ethiques Ethypharm 1194140*

  • Antiviral therapy
    Universitair Medische Centrum Utrecht 1194141*

  • Salts of cis-4-cyano-4-(3-cyclopentaloyloxy-4-methoxyphenyl)cyclohexan-1-carboxylate
    SmithKline Beecham 1194142*

  • IL-8 receptor antagonists
    SmithKline Beecham 1194143*

  • Antibacterial compounds
    SmithKline Beecham 1194144*

  • Stable xylometazoline and oxymetazoline solution
    Boehringer Ingelheim Zentrale 1194145*

  • Arylthazolidinedione and aryloxazolidinedione derivatives
    Merck 1194146*

  • Arylthiazolidinedione and aryloxazolidinedione derivatives
    Merck 1194147*

  • Cystic fibrosis medicaments
    University of Wales College of Medicine 1194148*

  • Cyclohexenyl-ethyl-thiourea compounds and use
    Parker Hughes Institute 1194149*

  • Use of nitroxides in wound healing and in the prevention of photodamage
    Bernstein, Eric 1194150*

  • Integrin receptor antagonists
    Merck 1194151*

  • SRC kinase inhibitor compounds
    Merck 1194152*

  • Taste-masked pharmaceutical liquid formulations
    Ortho-McNeil Pharmaceutical 1194153*

  • Use of propionic bacteria for producing propionic acid and/or propionates in the colon
    Laboratoires Standa 1194154*

  • Synergistic compsns containing lycopene and silymarin for treatment of liver disease
    Lycored Natural Products Industries 1194155*

  • Method of treating malignancies and viral infections and improving immune function with a dietary supplement
    Sun Farm Corporation 1194156*

  • D-form polypeptide which induces immune tolerance and methods of use
    Hisamitsu Pharmaceutical; The University of Kansas 1194157*

  • The use of the protein UK 114 fir inhibiting organ transplant rejection
    Zetesis 1194158*

  • Use of Interleukin-6 in treatment of obesity and obesity-related disorders
    Sahltech I Goeteburg 1194159*

  • A somatotropin compsn with improved syringeability
    LG Chem Investment 1194160*

  • Stable factor VII compsns
    Biovitrum 1194161*

  • Compsns and methods for the prevention, treatment and detection of tuberculosis and other diseases
    Ferry, James; Leishman, Kathryn 1194162*

  • Novel methods and medicament for treating infectious diseases involving microbial biofilms
    Perraudin, Jean-Paul 1194163*

  • Prion protein peptides and uses thereof
    Caprion Pharmaceuticals 1194164*

  • Tagged epitope protein transposable element
    Oregon Health Sciences University 1194165*

  • Aqueous immunologic adjuvant compsns of monophosphoryl lipid A
    Corixa 1194166*

  • Immunotherapy of autoimmune disorders using antibodies which target B-cells
    Immunomedics 1194167*

  • Methods and products for manipulating uncoupling protein expression
    University of Vermont and State Agricultural College 1194168*

  • Stabilised vitamin C formulations
    Igen 1194169*

  • Growth hormone formulations
    Grandis Biotech 1194170*

  • Nitric acid-producing hydrogel materials
    Rice University 1194171*

  • Compsns and methods for the treatment or prevention of autoimmune disorders
    The Scripps Research Institute 1194172*

  • X-ray guided drug delivery
    Vanderbilt University 1194173*

  • Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood
    The University of Alberta, Simon Fraser Uni., The Uni. of Victoria and The Uni. of British Columbia doing business as TRIUMF 1194174*

  • Cardioactive compsn comprising L-carnitine and its derivatives and I crataegus /I extracts
    Sigma-Tau Healthscience 1194186*

  • Antibody-based treatment for Streptococcus pneumoniae infection
    Aventis Pasteur 1194187*

  • A process for obtaining (nitroxymethyl)phenyl esters of salicylic acid derivatives
    Nicox 1194397*

  • Synthesis of (R) and (S)-aminocarnitine and their derivatives starting from D- and L-aspartic acid
    Sigma-Tau Industrie Farmaceutiche Riunite 1194398*

  • Novel aminoindanes
    Prescient Neuropharma 1194399*

  • 2-aminoindane analogues
    Prescient Neuropharma 1194400*

  • Diacylhydrazine derivatives
    Merck Patent 1194401*

  • Detergent compsns containing modified alkylaryl sulfonate surfactants
    Procter & Gamble 1194402*

  • Indanyl-substituted benzole carbonamide, method for the production thereof as a medicament and pharmaceutical preparations containing the same
    Aventis Pharma Deutschland 1194403*

  • Inhibitors of aspartyl protease
    Vertex Pharmaceuticals 1194404*

  • Sulphur-containing thyroxane derivatives and their use as hair growth promotors
    University of Texas Southwestern Medical Center 1194405*

  • Phenatyl-thiourea compounds for treating HIV infections
    Parker Hughes Institute 1194406*

  • N-cycloalkyl-3-alkenylbenzoyl-pyrazole derivatives
    BASF 1194407*

  • (a)-(a)'-substituted N-alkyl-3-alkenyklbenzoyl-pyrazol-derivatives
    BASF 1194408*

  • Pyrazolidinol compounds
    A-viral 1194409*

  • Benzimidazole derivatives and pharmaceutical compsns comprising these compounds
    Neurosearch 1194410*

  • Benzopyridazines
    Merck Patent 1194411*

  • Method for producing 4,6-dichloro-pyrimidine with acid chlorides
    Bayer 1194412*

  • Method for producing 4-chloro-6-hydroxypyrimidine
    Bayer 1194413*

  • Process for preparing 2-amino-4-(4-fluorophenyl)-6-alkylpyrimidine-5-carboxylate
    Lonza 1194414*

  • Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compsns containing the same, and a process for their preparation
    Egis Gy Gyszergy 1194415*

  • Halopyrimidines
    Bayer 1194416*

  • Phenoxy fluoropyrimidines
    Bayer 1194417*

  • Bicyclic heterocycles, medicaments containing them, their use and methods for the production thereof
    Boehringer Ingelheim 1194418*

  • Method for producing 2-heterocyclic methyl benzoic acid derivatives
    Bayer 1194419*

  • Preparation of an aromatic bisoxazoline
    DSM 1194420*

  • Selective NPY (Y5) antagonists
    Synaptic Pharmaceutical Corporation 1194421*

  • Biaryl compounds
    University of Texas Southwestern Medical Center 1194422*

  • Process for extraction and purification of paclitaxel from natural sources
    Chaichem Pharmaceuticals International 1194423*

  • Photochromic pyran derivatives
    Optische Werke 1194424*

  • Substituted benzimidazoles
    Aventis Pharma Deutschland 1194425*

  • Benzofuran derivatives
    Merck Patent 1194426*

  • Thiphene-ethyl thiourea compounds and use in the treatment of HIV
    Parker Hughes Institute 1194427*

  • Heteroalkyl protease inhibitors and diagnostic imaging agents
    3-Dimensional Pharmaceuticals 1194428*

  • Potassium channel openers
    Abbott Laboratories 1194429*

  • Novel process
    Novo Nordisk 1194430*

  • Boron-substituted cyclopenadienes and metal complexes thereof
    The Dow Chemical Company 1194431*

  • Magnesium-zirconium alkoxide complexes and polymerisation catalysts made therefrom
    Union Carbide Chemicals and Plastics Technology 1194432*

  • Piperazinone derivatives with alkoxysilane groups
    Bayer 1194433*

  • Antimicrobial siloxane quat formulations and the production and use thereof
    Clariant 1194434*

  • Bisphenol-A bis(diphenyl phosphate)-based flame retardant
    Albemarle Corp 1194435*

  • Sulphonamidomethyl phosphonate inhibitors of beta-lactamase
    Methylgene 1194436*

  • Diphosphine ligands for metal complexes
    Solvias 1194437*

  • Nitrates of bis-platinum complexes with polyamine
    Novuspharma 1194438*

  • Induction of pharmacological stress with adenosine receptor agonists
    The University of Virginia Patent Foundation 1194440*

  • You may also like